Scaling Biomanufacturing With Help From Advanced CMOS Sensor Technologies
March 20 (Thursday), 2025
11:30 am to 12:30 pm (EDT)
Virtual via Zoom
Presentation to be made available soon
Abstract: Biomanufacturing has the potential to improve supply chain security, reduce the environmental impact of chemical manufacturing, and enable new materials that cannot be synthesized by traditional routes. Achieving these goals demands that biomanufacturing be cost competitive with traditional manufacturing processes. Process automation and control is a key enabler to achieving cost competitiveness. Dr. Magyar will discuss Capra’s bioreactor technology and how innovative semiconductor-based sensor technologies being developed in collaboration with Boston University can enable the use of big data to optimize biomanufacturing processes and facilitate future autonomous operation.
Biography: Dr. Andrew Magyar is the co-founder and CTO of Capra Biosciences, based in Sterling, VA. He previously served as principal scientist at Draper Laboratory where he led large teams and complex R&D projects. Dr. Magyar has a Ph.D. in materials science from MIT, where he developed new bio-templated materials for photocatalytic water splitting. As a Harvard University postdoctoral fellow, he developed new nanofabrication methods to enable silicon carbide and diamond nanophotonics. In addition to leading Capra Biosciences, Andrew is working with others in Virginia to make it a magnet for advanced biotechnology firms.